I. A. Ovcharenko
I. A. Ovcharenko has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Olga S. Shevchenko
Харківський національний медичний університет
9 shared publications - Olha Pohorielova
Комунальне некомерційне підприємство Харківської обласної ради «Обласна клінічна психіатрична лікарня № 3», Харків, Україна
7 shared publications - Svitlana Matvyeyeva
Kharkiv National Medical University
5 shared publications - Liliia D. Todoriko
Bukovinian State Medical University
4 shared publications - Rostislav Shevchenko
Харківський національний медичний університет
4 shared publications - L. D. Todoriko
Bukovinian State Medical University, Chernivtsi, Ukraine
3 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 4,p. 106-116
Assessment of Stigmatisation of Tuberculosis Patients, People Living with HIV, and Individuals with Mental and Behavioural Disorders Among Higher Medical Education Students
Social determinants, including prejudice and social labelling (stigmatisation), exert a profound impact on population health outcomes and equity in healthcare. Stigmatisation leads to severe psychological, social, and financial repercussions for patients – fostering low self-esteem, depression, social isolation, and compromised treatment adherence. Despite its recognised burden on healthcare systems, detecting and controlling stigmatisation remains a complex task. Evaluating attitudes among future medical professionals is crucial to identifying latent biases and developing effective destigmatisation strategies. Objective — to evaluate the level of stigmatisation, tolerance, and social distance towards tuberculosis (TB) patients, people living with HIV (PLHIV), and individuals with mental and behavioral disorders among higher medical education students. Materials and methods. The study was conducted within the research project «Development of Innovative Methods for Improving the Information and Diagnostic Component of Infectious Disease Surveillance to Enhance the Biosecurity of Ukraine». A total of 158 medical students completed an anonymous online survey via Google Forms consisting of 30 questions (10 per diagnostic category). The questionnaire was developed by the authors based on frequently reported clinical instances of stigma and discrimination, utilising dichotomous and Likert scale responses. Results and discussion. The findings demonstrate a high baseline level of theoretical knowledge and legal awareness among students. Respondents overwhelmingly recognised equal societal rights. Tuberculosis: 94.8 % agreed to work alongside a recovered colleague, 98.3 % rejected a past TB diagnosis as valid grounds for employment denial, and 96.6 % debunked the myth that TB exclusively affects socially vulnerable populations. HIV/AIDS: 87.9 % affirmed equal educational rights without forced isolation, 75.9 % reported their attitude towards a classmate would remain unchanged upon learning of an HIV-positive status, and 81.0 % identified a desire to help as their primary reaction to a friend’s diagnosis. Mental health: 96.6 % rejected the belief that mental disorders stem solely from hereditary factors or antisocial lifestyles, and 89.7 % opposed employment discrimination based on psychiatric history. However, a marked paradox emerged between theoretical declarations and everyday domestic or personal behaviours: 55.2 % of students would attempt to conceal a family member’s TB diagnosis out of fear of social judgment. 53.4 % would refuse to share utensils or household items with an HIV-positive individual, and only 10.3 % would unequivocally agree to a romantic relationship with a person living with HIV. 58.6 % would refuse to share housing with a person diagnosed with bipolar affective disorder, and only 39.7 % felt comfortable in the company of someone open about psychiatric disorders. Furthermore, only 25.9 % to 29.3 % of students expressed complete confidence in their practical knowledge regarding infection prevention or psychological first aid. Conclusions. Future healthcare professionals exhibit strong theoretical tolerance and support for civil rights in administrative and academic settings. Nevertheless, latent stigma, subconscious wariness, and fear of public disapproval remain prevalent in private and everyday life scenarios. These results highlight an urgent necessity to modernise medical curricula by shifting focus from purely theoretical instruction towards interactive destigmatisation programmes, practical infection control training, and psychological preparation for clinical practice.
- 6 November 2026
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 4,p. 106-116
Open AccessAssessment of Stigmatisation of Tuberculosis Patients, People Living with HIV, and Individuals with Mental and Behavioural Disorders Among Higher Medical Education Students
Social determinants, including prejudice and social labelling (stigmatisation), exert a profound impact on population health outcomes and equity in healthcare. Stigmatisation leads to severe psychological, social, and financial repercussions for patients – fostering low self-esteem, depression, social isolation, and compromised treatment adherence. Despite its recognised burden on healthcare systems, detecting and controlling stigmatisation remains a complex task. Evaluating attitudes among future medical professionals is crucial to identifying latent biases and developing effective destigmatisation strategies. Objective — to evaluate the level of stigmatisation, tolerance, and social distance towards tuberculosis (TB) patients, people living with HIV (PLHIV), and individuals with mental and behavioral disorders among higher medical education students. Materials and methods. The study was conducted within the research project «Development of Innovative Methods for Improving the Information and Diagnostic Component of Infectious Disease Surveillance to Enhance the Biosecurity of Ukraine». A total of 158 medical students completed an anonymous online survey via Google Forms consisting of 30 questions (10 per diagnostic category). The questionnaire was developed by the authors based on frequently reported clinical instances of stigma and discrimination, utilising dichotomous and Likert scale responses. Results and discussion. The findings demonstrate a high baseline level of theoretical knowledge and legal awareness among students. Respondents overwhelmingly recognised equal societal rights. Tuberculosis: 94.8 % agreed to work alongside a recovered colleague, 98.3 % rejected a past TB diagnosis as valid grounds for employment denial, and 96.6 % debunked the myth that TB exclusively affects socially vulnerable populations. HIV/AIDS: 87.9 % affirmed equal educational rights without forced isolation, 75.9 % reported their attitude towards a classmate would remain unchanged upon learning of an HIV-positive status, and 81.0 % identified a desire to help as their primary reaction to a friend’s diagnosis. Mental health: 96.6 % rejected the belief that mental disorders stem solely from hereditary factors or antisocial lifestyles, and 89.7 % opposed employment discrimination based on psychiatric history. However, a marked paradox emerged between theoretical declarations and everyday domestic or personal behaviours: 55.2 % of students would attempt to conceal a family member’s TB diagnosis out of fear of social judgment. 53.4 % would refuse to share utensils or household items with an HIV-positive individual, and only 10.3 % would unequivocally agree to a romantic relationship with a person living with HIV. 58.6 % would refuse to share housing with a person diagnosed with bipolar affective disorder, and only 39.7 % felt comfortable in the company of someone open about psychiatric disorders. Furthermore, only 25.9 % to 29.3 % of students expressed complete confidence in their practical knowledge regarding infection prevention or psychological first aid. Conclusions. Future healthcare professionals exhibit strong theoretical tolerance and support for civil rights in administrative and academic settings. Nevertheless, latent stigma, subconscious wariness, and fear of public disapproval remain prevalent in private and everyday life scenarios. These results highlight an urgent necessity to modernise medical curricula by shifting focus from purely theoretical instruction towards interactive destigmatisation programmes, practical infection control training, and psychological preparation for clinical practice.
- Open Access
- 30 October 2025
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 4,p. 101-113
Explosive Lung Injury ( Review)
Modern patterns of terrorist activity and military operations worldwide have increased the potential casualties associated with explosions. However, few civilian doctors have experience in the treatment of patients with blast injuries, which highlights the need to improve knowledge about the physics, pathogenesis of blast injury and other associated types of injuries that may occur. Objective — to describe the main mechanisms of blast lung injury development and algorithms for the diagnosis and clinical management of such patients. Materials and methods. A total of 528 literature sources in the PubMed database were analysed for the key words «Blast lung injury» and 35 of them were selected for detailed further analysis. Results and discussion. Blast lung injury is a major cause of morbidity and mortality in explosion victims both at the scene and among the first survivors. Blast impact on the lungs results in rupture, haemorrhage, contusion and oedema, with subsequent ventilation-perfusion disorders. Blast lung injury is a clinical diagnosis characterised by respiratory distress and hypoxia, which may occur without apparent external chest injury. Conclusions. Blast lung injury is one of the most common causes of death in blast victims. Blast injuries should be managed by a multidisciplinary team that includes a trauma surgeon, general surgeon, ENT specialist, ophthalmologist, plastic surgeon, anaesthesiologist, intensive care physician and emergency department physician, and other specialists as needed. Mental health counselling is also recommended for these patients, as the development of acute stress disorder, adjustment disorders and post-traumatic stress disorder cannot be ruled out. If the injury is minor, the patient can be observed for 6—8 hours and discharged. However, all serious blast injuries require hospitalisation and monitoring; in addition, they have an extended rehabilitation phase.
- 30 October 2025
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 4,p. 101-113
Open AccessExplosive Lung Injury ( Review)
Modern patterns of terrorist activity and military operations worldwide have increased the potential casualties associated with explosions. However, few civilian doctors have experience in the treatment of patients with blast injuries, which highlights the need to improve knowledge about the physics, pathogenesis of blast injury and other associated types of injuries that may occur. Objective — to describe the main mechanisms of blast lung injury development and algorithms for the diagnosis and clinical management of such patients. Materials and methods. A total of 528 literature sources in the PubMed database were analysed for the key words «Blast lung injury» and 35 of them were selected for detailed further analysis. Results and discussion. Blast lung injury is a major cause of morbidity and mortality in explosion victims both at the scene and among the first survivors. Blast impact on the lungs results in rupture, haemorrhage, contusion and oedema, with subsequent ventilation-perfusion disorders. Blast lung injury is a clinical diagnosis characterised by respiratory distress and hypoxia, which may occur without apparent external chest injury. Conclusions. Blast lung injury is one of the most common causes of death in blast victims. Blast injuries should be managed by a multidisciplinary team that includes a trauma surgeon, general surgeon, ENT specialist, ophthalmologist, plastic surgeon, anaesthesiologist, intensive care physician and emergency department physician, and other specialists as needed. Mental health counselling is also recommended for these patients, as the development of acute stress disorder, adjustment disorders and post-traumatic stress disorder cannot be ruled out. If the injury is minor, the patient can be observed for 6—8 hours and discharged. However, all serious blast injuries require hospitalisation and monitoring; in addition, they have an extended rehabilitation phase.
- Open Access
- 22 May 2024
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 2,p. 8-13
Dependence of Human-Beta-Defensin-1, Ferritin and Interleukin-6 Levels on the Spectrum of Drug Resistance and Regimens of Anti-Tuberculosis Therapy in Patients with Pulmonary Tuberculosis
Objective — to explore the correlation between the levels of Human-beta-defensin-1, ferritin and Interleukin-6 and the spectrum of drug resistance, as well as the treatment regimens in patients with pulmonary tuberculosis. Materials and methods. This study included 100 patients with pulmonary tuberculosis, divided into two groups: Group 1 (n = 52) with drug-susceptible tuberculosis and Group 2 (n = 48) with drug-resistant tuberculosis, including patients with multidrug-resistant (MDR-TB) and pre-extensively drug-resistant tuberculosis. Diagnostic assessments included chest X-rays and sputum examinations using microscopic, molecular-genetic and cultural methods. Levels of HBD-1, ferritin and IL-6 were measured using ELISA on fasting blood samples at the onset of treatment and after 60 days. Data analysis was performed using Statistica 8.0 software. Results and discussion. In patients with drug-susceptible tuberculosis, the initial levels of biomarkers were significantly higher compared to their levels after 60 treatment doses. Specifically, Human-beta-defensin-1 (HBD-1) decreased from (23.38 ± 3.48) pg/mL initially to (11.83 ± 2.30) pg/mL after 60 doses; ferritin decreased from (117.47 ± 12.34) ng/mL to (85.74 ± 13.25) ng/mL; and Interleukin-6 (IL-6) decreased from (87.49 ± 8.43) pg/mL to (51.37 ± 5.15) pg/mL. Conversely, in patients with drug-resistant tuberculosis, while IL-6 levels also showed a significant decrease from (99.78 ± 8.52) pg/mL at the onset to (67.59 ± 8.28) pg/mL after 60 doses, both HBD-1 and ferritin levels increased post-treatment. HBD-1 levels rose from (21.43 ± 4.39) pg/mL to (30.69 ± 5.06) pg/mL, and ferritin levels from (105.13 ± 8.72) ng/mL to (153.43 ± 20.29) ng/mL. Conclusions. In patients with drug-susceptible tuberculosis, levels of HBD-1, ferritin and IL-6 significantly decrease after 60 days of treatment. This decrease correlates with a reduction in clinical and radiographic symptoms of tuberculosis and the cessation of bacterial excretion. Conversely, in patients with drug-resistant tuberculosis, levels of HBD-1 and ferritin increase after 60 doses of treatment, likely due to a delayed reduction in bacterial load and a prolonged active immune response. However, IL-6 levels significantly decrease, suggesting its primary role in initiating the anti-tuberculosis immune response. The lack of significant differences in these biomarkers between patients with drug-susceptible and drug-resistant tuberculosis at the onset of treatment suggests that drug resistance does not inherently affect the severity of tuberculosis inflammation or the activity of the initial anti-tuberculosis immune response.
- 22 May 2024
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 2,p. 8-13
Open AccessDependence of Human-Beta-Defensin-1, Ferritin and Interleukin-6 Levels on the Spectrum of Drug Resistance and Regimens of Anti-Tuberculosis Therapy in Patients with Pulmonary Tuberculosis
Objective — to explore the correlation between the levels of Human-beta-defensin-1, ferritin and Interleukin-6 and the spectrum of drug resistance, as well as the treatment regimens in patients with pulmonary tuberculosis. Materials and methods. This study included 100 patients with pulmonary tuberculosis, divided into two groups: Group 1 (n = 52) with drug-susceptible tuberculosis and Group 2 (n = 48) with drug-resistant tuberculosis, including patients with multidrug-resistant (MDR-TB) and pre-extensively drug-resistant tuberculosis. Diagnostic assessments included chest X-rays and sputum examinations using microscopic, molecular-genetic and cultural methods. Levels of HBD-1, ferritin and IL-6 were measured using ELISA on fasting blood samples at the onset of treatment and after 60 days. Data analysis was performed using Statistica 8.0 software. Results and discussion. In patients with drug-susceptible tuberculosis, the initial levels of biomarkers were significantly higher compared to their levels after 60 treatment doses. Specifically, Human-beta-defensin-1 (HBD-1) decreased from (23.38 ± 3.48) pg/mL initially to (11.83 ± 2.30) pg/mL after 60 doses; ferritin decreased from (117.47 ± 12.34) ng/mL to (85.74 ± 13.25) ng/mL; and Interleukin-6 (IL-6) decreased from (87.49 ± 8.43) pg/mL to (51.37 ± 5.15) pg/mL. Conversely, in patients with drug-resistant tuberculosis, while IL-6 levels also showed a significant decrease from (99.78 ± 8.52) pg/mL at the onset to (67.59 ± 8.28) pg/mL after 60 doses, both HBD-1 and ferritin levels increased post-treatment. HBD-1 levels rose from (21.43 ± 4.39) pg/mL to (30.69 ± 5.06) pg/mL, and ferritin levels from (105.13 ± 8.72) ng/mL to (153.43 ± 20.29) ng/mL. Conclusions. In patients with drug-susceptible tuberculosis, levels of HBD-1, ferritin and IL-6 significantly decrease after 60 days of treatment. This decrease correlates with a reduction in clinical and radiographic symptoms of tuberculosis and the cessation of bacterial excretion. Conversely, in patients with drug-resistant tuberculosis, levels of HBD-1 and ferritin increase after 60 doses of treatment, likely due to a delayed reduction in bacterial load and a prolonged active immune response. However, IL-6 levels significantly decrease, suggesting its primary role in initiating the anti-tuberculosis immune response. The lack of significant differences in these biomarkers between patients with drug-susceptible and drug-resistant tuberculosis at the onset of treatment suggests that drug resistance does not inherently affect the severity of tuberculosis inflammation or the activity of the initial anti-tuberculosis immune response.
- Open Access
- 29 February 2024
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 1,p. 15-20
Human-Beta-Defensin-1, Ferritin, Interleukin-6 and their Relationship with Clinical and Laboratory Parameters of the Severity of the Tuberculosis Process
Establishing relationships between clinical and laboratory parameters, such as general patient’s state, parameters of complete blood count and blood biochemistry and markers of the course of tuberculosis in the future can be used to predict the severity of dysfunction of various organs and tissues in patients with tuberculosis and in particular in patients who receive anti-tuberculosis treatment. Objective — to investigate the relationship between biochemical markers, namely Human-beta-defensin-1, ferritin and interleukin-6, and clinical and laboratory indicators of the severity of the tuberculosis process. Materials and methods. 100 patients diagnosed with pulmonary tuberculosis were included in the study. After receiving 60 doses of anti-tuberculosis treatment, the patients were retrospectively divided into 2 groups. Group 1 (n = 77) consisted of patients in whom sputum conversion was observed after 60 doses of treatment, determined by sputum microscopy. Group 2 (n = 23) comprised patients in whom bacterial secretion was maintained after 60 doses of treatment, as detected by microscopy. In addition to the routine studies provided for the monitoring of patients with tuberculosis by the current orders of the Ministry of Health of Ukraine, the levels of Human-beta-defensin-1, ferritin and interleukin-6 (IL-6) in the fasting blood were additionally measured by ELISA at the beginning of treatment and after 60 days. Statistical data processing was carried out using the Statistica 8.0 software environment. Results. A comparison of the investigated parameters between groups at the beginning of treatment showed significantly higher values of Human-beta-defensin-1 (Group 1 — (18.97 ± 2.42) pg/ml, Group 2 — (55.02 ± ± 15.69) pg/ml), ferritin (Group 1 — (94.86 ± 6.02) ng/ml, Group 2 — (141.61 ± 24.66) ng/ml) and IL-6 (Group 1 — (80.33 ± 5.03) pg/ml, Group 2 — (110.13 ± 10.35) pg/ml) in patients with positive sputum microscopy after 60 doses of treatment, p < 0.05. All studied markers demonstrated a reliable positive relationship with the massiveness of bacterial excretion, a conditional indicator of the severity of clinical symptoms and signs, ESR and urea level, as well as reliable negative correlations with creatinine level. In addition, patients with a lower body mass index were found to have higher levels of Human-beta-defensin-1 and ferritin. Higher levels of Human-beta-defensin-1 and ferritin are associated with lower hemoglobin levels (Human-beta-defensin-1 was also negatively correlated with erythrocyte count). An increase in the leukocytes level is accompanied by a significant increase in the level of Human-beta-defensin-1 and IL-6. Additionally, a significant negative correlation was found between the level of glucose and ferritin, as well as between the level of bilirubin and ferritin and IL-6. Conclusions. The determined significantly higher levels of Human-beta-defensin-1, ferritin and interleukin-6 in patients in whom sputum microscopy was positive after 60 doses of treatment allow considering the investigated biochemical parameters as markers of the ineffectiveness of anti-tuberculosis therapy. The identified positive relationships with the severity of clinical symptoms indicate the possibility of using the studied parameters as markers of the severity of the tuberculosis course. The possibility of using Human-beta-defensin-1 and ferritin as markers of anemia was also found. Correlations with parameters of blood biochemistry allow us to talk about increased levels of Human-beta-defensin-1, ferritin and interleukin-6 against the background of kidney damage. - Установлення зв’язків між клініко-лабораторними параметрами (загальний стан пацієнта, показники клінічного і біохімічного аналізів крові) та маркерами перебігу туберкульозу в перспективі може бути використане для прогнозування тяжкості порушення функціонування різних органів і тканин у хворих на туберкульоз, зокрема в пацієнтів, які отримують протитуберкульозне лікування.Мета роботи — дослідити зв’язки між біохімічними маркерами (β-дефензин-1, феритин, інтерлейкін-6 (ІЛ-6)) і клінічними та лабораторними показниками тяжкості туберкульозного процесу. Матеріали та методи. У дослідження було залучено 100 хворих на туберкульоз легень. Після отримання 60 доз протитуберкульозного лікування пацієнтів ретроспективно розподілили на дві групи: 77 пацієнтів, у яких зареєстрували припинення бактеріовиділення (за даними мікроскопії мокротиння), і 23 пацієнти, у яких зберігалося бактеріовиділення (за даними мікроскопії мокротиння). Крім рутинних досліджень, передбачених для моніторингу пацієнтів із туберкульозом наказами МОЗ України щодо ведення хворих на туберкульоз, вимірювали рівень β-дефензину-1, феритину та ІЛ-6 у крові натще методом імуноферментного аналізу на початку лікування та через 60 днів. Статистичну обробку даних проведено за допомогою програмного...
- 29 February 2024
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 1,p. 15-20
Open AccessHuman-Beta-Defensin-1, Ferritin, Interleukin-6 and their Relationship with Clinical and Laboratory Parameters of the Severity of the Tuberculosis Process
Establishing relationships between clinical and laboratory parameters, such as general patient’s state, parameters of complete blood count and blood biochemistry and markers of the course of tuberculosis in the future can be used to predict the severity of dysfunction of various organs and tissues in patients with tuberculosis and in particular in patients who receive anti-tuberculosis treatment. Objective — to investigate the relationship between biochemical markers, namely Human-beta-defensin-1, ferritin and interleukin-6, and clinical and laboratory indicators of the severity of the tuberculosis process. Materials and methods. 100 patients diagnosed with pulmonary tuberculosis were included in the study. After receiving 60 doses of anti-tuberculosis treatment, the patients were retrospectively divided into 2 groups. Group 1 (n = 77) consisted of patients in whom sputum conversion was observed after 60 doses of treatment, determined by sputum microscopy. Group 2 (n = 23) comprised patients in whom bacterial secretion was maintained after 60 doses of treatment, as detected by microscopy. In addition to the routine studies provided for the monitoring of patients with tuberculosis by the current orders of the Ministry of Health of Ukraine, the levels of Human-beta-defensin-1, ferritin and interleukin-6 (IL-6) in the fasting blood were additionally measured by ELISA at the beginning of treatment and after 60 days. Statistical data processing was carried out using the Statistica 8.0 software environment. Results. A comparison of the investigated parameters between groups at the beginning of treatment showed significantly higher values of Human-beta-defensin-1 (Group 1 — (18.97 ± 2.42) pg/ml, Group 2 — (55.02 ± ± 15.69) pg/ml), ferritin (Group 1 — (94.86 ± 6.02) ng/ml, Group 2 — (141.61 ± 24.66) ng/ml) and IL-6 (Group 1 — (80.33 ± 5.03) pg/ml, Group 2 — (110.13 ± 10.35) pg/ml) in patients with positive sputum microscopy after 60 doses of treatment, p < 0.05. All studied markers demonstrated a reliable positive relationship with the massiveness of bacterial excretion, a conditional indicator of the severity of clinical symptoms and signs, ESR and urea level, as well as reliable negative correlations with creatinine level. In addition, patients with a lower body mass index were found to have higher levels of Human-beta-defensin-1 and ferritin. Higher levels of Human-beta-defensin-1 and ferritin are associated with lower hemoglobin levels (Human-beta-defensin-1 was also negatively correlated with erythrocyte count). An increase in the leukocytes level is accompanied by a significant increase in the level of Human-beta-defensin-1 and IL-6. Additionally, a significant negative correlation was found between the level of glucose and ferritin, as well as between the level of bilirubin and ferritin and IL-6. Conclusions. The determined significantly higher levels of Human-beta-defensin-1, ferritin and interleukin-6 in patients in whom sputum microscopy was positive after 60 doses of treatment allow considering the investigated biochemical parameters as markers of the ineffectiveness of anti-tuberculosis therapy. The identified positive relationships with the severity of clinical symptoms indicate the possibility of using the studied parameters as markers of the severity of the tuberculosis course. The possibility of using Human-beta-defensin-1 and ferritin as markers of anemia was also found. Correlations with parameters of blood biochemistry allow us to talk about increased levels of Human-beta-defensin-1, ferritin and interleukin-6 against the background of kidney damage. - Установлення зв’язків між клініко-лабораторними параметрами (загальний стан пацієнта, показники клінічного і біохімічного аналізів крові) та маркерами перебігу туберкульозу в перспективі може бути використане для прогнозування тяжкості порушення функціонування різних органів і тканин у хворих на туберкульоз, зокрема в пацієнтів, які отримують протитуберкульозне лікування.Мета роботи — дослідити зв’язки між біохімічними маркерами (β-дефензин-1, феритин, інтерлейкін-6 (ІЛ-6)) і клінічними та лабораторними показниками тяжкості туберкульозного процесу. Матеріали та методи. У дослідження було залучено 100 хворих на туберкульоз легень. Після отримання 60 доз протитуберкульозного лікування пацієнтів ретроспективно розподілили на дві групи: 77 пацієнтів, у яких зареєстрували припинення бактеріовиділення (за даними мікроскопії мокротиння), і 23 пацієнти, у яких зберігалося бактеріовиділення (за даними мікроскопії мокротиння). Крім рутинних досліджень, передбачених для моніторингу пацієнтів із туберкульозом наказами МОЗ України щодо ведення хворих на туберкульоз, вимірювали рівень β-дефензину-1, феритину та ІЛ-6 у крові натще методом імуноферментного аналізу на початку лікування та через 60 днів. Статистичну обробку даних проведено за допомогою програмного...
- Open Access
- 20 September 2023
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 3,p. 5-10
External Respiratory Function, Inflammation Markers, and Life Quality Depending on the Volume of Tuberculosis Lung Lesion
Туберкульоз — поширена хвороба у багатьох країнах, тому розуміння його впливу на якість життя та функцію дихання, а також зв’язок цих показників з біохімічними маркерами перебігу й ефективності лікування туберкульозу має важливе значення для оцінки нових методів лікування та профілактики. Мета роботи — дослідити зв’язок між функцією зовнішнього дихання, рівнем β-дефензину-1, феритину, інтерлейкіну-6, якістю життя та об’ємом туберкульозного ураження легень. Матеріали та методи. У дослідження було залучено 100 пацієнтів із туберкульозом легень. Пацієнтів розподілили на дві групи відповідно до об’єму туберкульозного ураження: група 1 (n = 36) — ураження в межах однієї легені, група 2 (n = 64) — ураження обох легень. Обстеження пацієнтів проводили згідно зі стандартами надання медичної допомоги хворим на туберкульоз. Додатково методом імуноферментного аналізу визначали рівень феритину, інтерлейкіну (ІЛ)-6 та β-дефензину-1 у крові натще, проводили спірографію для визначення показників функції зовнішнього дихання, а також анкетування за опитувальником SF-36 із визначенням основних показників якості життя на початку лікування та через 60 днів. Статистичну обробку даних проводили за допомогою програмного середовища Statistica 8.0. Результати та обговорення. Порівняння спірометричних показників між групами очікувано показало статистично значущо нижчі параметри функції зовнішнього дихання у пацієнтів з двобічним туберкульозним ураженням порівняно із пацієнтами з однобічним ураженням. Зниження показників функції зовнішнього дихання супроводжувалося відповідним зниженням якості життя, більш вираженим у групі 2. Зміни відбувалися на тлі статистично значущого підвищення досліджуваних біохімічних маркерів у групі 2 порівняно з групою 1: рівень β-дефензину-1 у групі 1 становив у середньому (8,11 ± 1,78) пг/мл, у групі 2 — (30,14 ± 3,89) пг/мл (p < 0,05), феритину — відповідно (94,19 ± 1,18) і (113,45 ± 4,77) нг/мл (p < 0,05), ІЛ-6 — (81,43 ± 1,14) та (103,34 ± 3,46) пг/мл (p < 0,05). При дослідженні кореляційних зв’язків між рівнями β-дефензину-1, феритину, ІЛ-6 та показниками якості життя за опитувальником SF-36 установлено статистично значущі обернено пропорційні зв’язки між усіма показниками якості життя і рівнями β-дефензину-1 та феритину. Дослідження кореляційних зв’язків між рівнями β-дефензину-1, феритину, ІЛ-6 та показниками функції зовнішнього дихання виявило, що β-дефензин-1 має статистично значущі обернено пропорційні зв’язки як з об’ємними, так і зі швидкісними показниками (– 0,24… – 0,32), ІЛ-6 — лише із форсованою життєвою ємністю легень (rs = – 0,42) та об’ємом форсованого видиху за першу секунду (rs = – 0,41), але ці кореляційні зв’язки є сильнішими порівняно з β-дефензином-1. Висновки. Збільшення об’єму туберкульозного ураження легень призводить до виразнішого порушення функції зовнішнього дихання і, як наслідок, — до зниження якості життя пацієнтів. Ці зміни супроводжуються підвищенням рівня β-дефензину-1, феритину та ІЛ-6, тому зазначені біомаркери є перспективними предикторами погіршення функції зовнішнього дихання та якості життя. Сильніші кореляції з показниками якості життя продемонстрували β-дефензин-1 та феритин. Досліджувані маркери мають обернено пропорційні зв’язки із показниками як рестриктивних, так і обструктивних...
- 20 September 2023
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 3,p. 5-10
Open AccessExternal Respiratory Function, Inflammation Markers, and Life Quality Depending on the Volume of Tuberculosis Lung Lesion
Туберкульоз — поширена хвороба у багатьох країнах, тому розуміння його впливу на якість життя та функцію дихання, а також зв’язок цих показників з біохімічними маркерами перебігу й ефективності лікування туберкульозу має важливе значення для оцінки нових методів лікування та профілактики. Мета роботи — дослідити зв’язок між функцією зовнішнього дихання, рівнем β-дефензину-1, феритину, інтерлейкіну-6, якістю життя та об’ємом туберкульозного ураження легень. Матеріали та методи. У дослідження було залучено 100 пацієнтів із туберкульозом легень. Пацієнтів розподілили на дві групи відповідно до об’єму туберкульозного ураження: група 1 (n = 36) — ураження в межах однієї легені, група 2 (n = 64) — ураження обох легень. Обстеження пацієнтів проводили згідно зі стандартами надання медичної допомоги хворим на туберкульоз. Додатково методом імуноферментного аналізу визначали рівень феритину, інтерлейкіну (ІЛ)-6 та β-дефензину-1 у крові натще, проводили спірографію для визначення показників функції зовнішнього дихання, а також анкетування за опитувальником SF-36 із визначенням основних показників якості життя на початку лікування та через 60 днів. Статистичну обробку даних проводили за допомогою програмного середовища Statistica 8.0. Результати та обговорення. Порівняння спірометричних показників між групами очікувано показало статистично значущо нижчі параметри функції зовнішнього дихання у пацієнтів з двобічним туберкульозним ураженням порівняно із пацієнтами з однобічним ураженням. Зниження показників функції зовнішнього дихання супроводжувалося відповідним зниженням якості життя, більш вираженим у групі 2. Зміни відбувалися на тлі статистично значущого підвищення досліджуваних біохімічних маркерів у групі 2 порівняно з групою 1: рівень β-дефензину-1 у групі 1 становив у середньому (8,11 ± 1,78) пг/мл, у групі 2 — (30,14 ± 3,89) пг/мл (p < 0,05), феритину — відповідно (94,19 ± 1,18) і (113,45 ± 4,77) нг/мл (p < 0,05), ІЛ-6 — (81,43 ± 1,14) та (103,34 ± 3,46) пг/мл (p < 0,05). При дослідженні кореляційних зв’язків між рівнями β-дефензину-1, феритину, ІЛ-6 та показниками якості життя за опитувальником SF-36 установлено статистично значущі обернено пропорційні зв’язки між усіма показниками якості життя і рівнями β-дефензину-1 та феритину. Дослідження кореляційних зв’язків між рівнями β-дефензину-1, феритину, ІЛ-6 та показниками функції зовнішнього дихання виявило, що β-дефензин-1 має статистично значущі обернено пропорційні зв’язки як з об’ємними, так і зі швидкісними показниками (– 0,24… – 0,32), ІЛ-6 — лише із форсованою життєвою ємністю легень (rs = – 0,42) та об’ємом форсованого видиху за першу секунду (rs = – 0,41), але ці кореляційні зв’язки є сильнішими порівняно з β-дефензином-1. Висновки. Збільшення об’єму туберкульозного ураження легень призводить до виразнішого порушення функції зовнішнього дихання і, як наслідок, — до зниження якості життя пацієнтів. Ці зміни супроводжуються підвищенням рівня β-дефензину-1, феритину та ІЛ-6, тому зазначені біомаркери є перспективними предикторами погіршення функції зовнішнього дихання та якості життя. Сильніші кореляції з показниками якості життя продемонстрували β-дефензин-1 та феритин. Досліджувані маркери мають обернено пропорційні зв’язки із показниками як рестриктивних, так і обструктивних...
- Open Access
- 15 June 2023
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 2,p. 7-14
Ferritin, IL-6 and human-beta-defensin-1 as prognostic markers of the course severity and treatment effectiveness of pulmonary tuberculosis
Current methods of investigation in TB patients, namely sputum microscopy, culture, and molecular genetic methods, although well-studied, have a number of disadvantages, such as low sensitivity, long time required to obtain results, or high cost. Because of this, the search for alternative diagnostic tools and methods for predicting the course and effectiveness of treatment in patients with tuberculosis becomes relevant. In this study, ferritin, interleukin-6 (IL-6), and human-beta-defensin-1 (HBD-1) were selected for comparison of prognostic performance. Objective — to investigate the dynamics of ferritin, IL-6, and human-beta-defensin-1 levels against the background of the intensive phase of pulmonary tuberculosis therapy and to identify the most effective marker for predicting the effectiveness of treatment. Materials and methods. 100 patients with pulmonary tuberculosis and 20 healthy individuals were included in the study. Examination of patients was carried out according to the current standards of providing medical care to tuberculosis patients. In addition, the patients' fasting blood ferritin, IL-6 and HBD-1 levels were determined at the beginning of treatment and after 60 days. Healthy individuals from the control group had a single determination of ferritin, IL-6 and HBD-1 blood levels on an empty stomach. Results and discussion. At the beginning of treatment, the ferritin level was significantly lower (95.95 ± ± 8.68) ng/ml in patients who later effectively completed the intensive phase of anti-tuberculosis treatment than in patients with ineffective intensive phase of treatment (152.27 ± 8.85) ng/ml. The same trend persisted after 60 days: in the effective intensive phase — (123.87 ± 13.39) ng/ml, in the ineffective one — (239.76 ± 12.91) ng/ml, p < 0.05. In effective intensive phase of antituberculosis treatment, the level of IL-6 was significantly lower. Thus, at the beginning of treatment, it was (82.59 ± 6.89) pg/ml in patients with an effective intensive phase of treatment and (146.42 ± 8.04) pg/ml in patients with ineffective intensive treatment phase. After 60 days, it was (48.88 ± 4.19) pg/ml in patients with an effective intensive phase of treatment and (142.89 ± 9.11) pg/ml in patients with ineffective intensive treatment phase, p < 0.05. The level of HBD-1 was higher when the intensive phase of antituberculosis therapy was ineffective, as when measured at the beginning of treatment (effective intensive phase — (18.71 ± 3.31) pg/ml, ineffective intensive phase — (32.79 ± 8.31) pg/ml), as well as when measured after 60 days (effective intensive phase — (19.93 ± 3.58) pg/ml, ineffective intensive phase — (42.92 ± 12.99) pg/ml, p < 0.05). Conclusions. Levels of ferritin, IL-6 and HBD-1 are significantly increased in tuberculosis patients compared to healthy individuals, which allows them to be considered as markers of tuberculosis inflammation. Higher concentrations of these markers, both at the beginning of treatment and after 60 doses, are predictors of failure of antituberculosis therapy. The strongest relationship between the studied markers and parameters of the severity of the tuberculosis process is observed in the study of HBD-1, which allows us to consider it as the most effective marker of the severity of the course among presented ones.
- 15 June 2023
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 2,p. 7-14
Open AccessFerritin, IL-6 and human-beta-defensin-1 as prognostic markers of the course severity and treatment effectiveness of pulmonary tuberculosis
Current methods of investigation in TB patients, namely sputum microscopy, culture, and molecular genetic methods, although well-studied, have a number of disadvantages, such as low sensitivity, long time required to obtain results, or high cost. Because of this, the search for alternative diagnostic tools and methods for predicting the course and effectiveness of treatment in patients with tuberculosis becomes relevant. In this study, ferritin, interleukin-6 (IL-6), and human-beta-defensin-1 (HBD-1) were selected for comparison of prognostic performance. Objective — to investigate the dynamics of ferritin, IL-6, and human-beta-defensin-1 levels against the background of the intensive phase of pulmonary tuberculosis therapy and to identify the most effective marker for predicting the effectiveness of treatment. Materials and methods. 100 patients with pulmonary tuberculosis and 20 healthy individuals were included in the study. Examination of patients was carried out according to the current standards of providing medical care to tuberculosis patients. In addition, the patients' fasting blood ferritin, IL-6 and HBD-1 levels were determined at the beginning of treatment and after 60 days. Healthy individuals from the control group had a single determination of ferritin, IL-6 and HBD-1 blood levels on an empty stomach. Results and discussion. At the beginning of treatment, the ferritin level was significantly lower (95.95 ± ± 8.68) ng/ml in patients who later effectively completed the intensive phase of anti-tuberculosis treatment than in patients with ineffective intensive phase of treatment (152.27 ± 8.85) ng/ml. The same trend persisted after 60 days: in the effective intensive phase — (123.87 ± 13.39) ng/ml, in the ineffective one — (239.76 ± 12.91) ng/ml, p < 0.05. In effective intensive phase of antituberculosis treatment, the level of IL-6 was significantly lower. Thus, at the beginning of treatment, it was (82.59 ± 6.89) pg/ml in patients with an effective intensive phase of treatment and (146.42 ± 8.04) pg/ml in patients with ineffective intensive treatment phase. After 60 days, it was (48.88 ± 4.19) pg/ml in patients with an effective intensive phase of treatment and (142.89 ± 9.11) pg/ml in patients with ineffective intensive treatment phase, p < 0.05. The level of HBD-1 was higher when the intensive phase of antituberculosis therapy was ineffective, as when measured at the beginning of treatment (effective intensive phase — (18.71 ± 3.31) pg/ml, ineffective intensive phase — (32.79 ± 8.31) pg/ml), as well as when measured after 60 days (effective intensive phase — (19.93 ± 3.58) pg/ml, ineffective intensive phase — (42.92 ± 12.99) pg/ml, p < 0.05). Conclusions. Levels of ferritin, IL-6 and HBD-1 are significantly increased in tuberculosis patients compared to healthy individuals, which allows them to be considered as markers of tuberculosis inflammation. Higher concentrations of these markers, both at the beginning of treatment and after 60 doses, are predictors of failure of antituberculosis therapy. The strongest relationship between the studied markers and parameters of the severity of the tuberculosis process is observed in the study of HBD-1, which allows us to consider it as the most effective marker of the severity of the course among presented ones.
- Open Access
- 15 March 2023
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 1,p. 87-92
Ferritin as proinflamatory biomarker of iron metabolism in tuberculosis patients (review)
Традиційні методи діагностики туберкульозу (ТБ), зокрема мікроскопія мазка мокротиння і посів на живильні середовища для виявлення Mycobacterium tuberculosis, потребують багато часу або мають незадовільну чутливість. Рання діагностика ТБ з високою точністю і чутливістю має важливе значення для результатів лікування пацієнтів та профілактики. Тому актуальним є пошук нових методів діагностики ТБ, що ґрунтуються на біомаркерах, асоційованих з ТБ, зі швидкою доступністю результатів, які не потребують аналізу мокротиння, є недорогими і мають точні характеристики. Мета роботи — вивчити механізми участі феритину в патогенезі ТБ за даними літератури. Матеріали та методи. Для дослідження знайдено 242 літературних джерела у системі PubMed за запитом Ferritin AND Tuberculosis, з них 40 відібрані для подальшого детального вивчення. Результати та обговорення. Дослідження показали, що у пацієнтів з ТБ концентрація сироваткового заліза і трансферину нижча, а рівень феритину вищий порівняно з особами без ТБ. Ці відхилення в концентрації феритину і трансферину зазвичай нормалізуються після лікування. Зменшення вмісту трансферину пов’язане як з раннім, так і з пізнім прогресуванням ТБ, а вищий рівень феритину та гепсидину — з вищим ризиком раннього прогресування ТБ в осіб, які контактували з хворими на ТБ. Статус біомаркерів обміну заліза можна використовувати як індикатор неефективності лікування (низький вміст феритину) та смертності (високий рівень феритину). Низька концентрація трансферину і сироваткового заліза, а також високий рівень феритину в інфікованих вірусом імунодефіциту людини пацієнтів асоціюються з підвищеним ризиком захворюваності та рецидиву ТБ. Висновки. Обмін заліза у Mycobacterium tuberculosis та організмі господаря тісно пов’язаний та відіграє важливу роль у патогенезі ТБ. Показники обміну заліза є перспективними маркерами як перебігу, так і ефективності лікування ТБ. Зміни рівня феритину можуть бути предикторами як неефективності лікування ТБ, так і смертності від цього захворювання, тому прогностична цінність цього маркера перебігу туберкульозного процесу потребує детальнішого вивчення.
- 15 March 2023
- Published by Publishing Company VIT-A-POL in Tuberculosis, Lung Diseases, HIV Infection
- No. 1,p. 87-92
Open AccessFerritin as proinflamatory biomarker of iron metabolism in tuberculosis patients (review)
Традиційні методи діагностики туберкульозу (ТБ), зокрема мікроскопія мазка мокротиння і посів на живильні середовища для виявлення Mycobacterium tuberculosis, потребують багато часу або мають незадовільну чутливість. Рання діагностика ТБ з високою точністю і чутливістю має важливе значення для результатів лікування пацієнтів та профілактики. Тому актуальним є пошук нових методів діагностики ТБ, що ґрунтуються на біомаркерах, асоційованих з ТБ, зі швидкою доступністю результатів, які не потребують аналізу мокротиння, є недорогими і мають точні характеристики. Мета роботи — вивчити механізми участі феритину в патогенезі ТБ за даними літератури. Матеріали та методи. Для дослідження знайдено 242 літературних джерела у системі PubMed за запитом Ferritin AND Tuberculosis, з них 40 відібрані для подальшого детального вивчення. Результати та обговорення. Дослідження показали, що у пацієнтів з ТБ концентрація сироваткового заліза і трансферину нижча, а рівень феритину вищий порівняно з особами без ТБ. Ці відхилення в концентрації феритину і трансферину зазвичай нормалізуються після лікування. Зменшення вмісту трансферину пов’язане як з раннім, так і з пізнім прогресуванням ТБ, а вищий рівень феритину та гепсидину — з вищим ризиком раннього прогресування ТБ в осіб, які контактували з хворими на ТБ. Статус біомаркерів обміну заліза можна використовувати як індикатор неефективності лікування (низький вміст феритину) та смертності (високий рівень феритину). Низька концентрація трансферину і сироваткового заліза, а також високий рівень феритину в інфікованих вірусом імунодефіциту людини пацієнтів асоціюються з підвищеним ризиком захворюваності та рецидиву ТБ. Висновки. Обмін заліза у Mycobacterium tuberculosis та організмі господаря тісно пов’язаний та відіграє важливу роль у патогенезі ТБ. Показники обміну заліза є перспективними маркерами як перебігу, так і ефективності лікування ТБ. Зміни рівня феритину можуть бути предикторами як неефективності лікування ТБ, так і смертності від цього захворювання, тому прогностична цінність цього маркера перебігу туберкульозного процесу потребує детальнішого вивчення.
- Open Access
- 19 November 2019
- Published by Communicable Diseases Intensive Care Association in Infusion & Chemotherapy
- No. 3
Study of Mechanisms of Pulmonal Tissue Treatment in Destructive Tuberculosis
Introduction. Disruption of the extracellular matrix is one of the most important pathological events in the formation of residual changes in lung tissue in tuberculous inflammation. Аim. Investigation of the dynamics of connective tissue reorganization in lung tuberculosis with a different profile of pathogen resistance to antituberculosis drugs. Materials and methods. 124 patients with new cases of pulmonary TB: group I (n=84) – patients with multidrugresistant TB; group II (n=40) – patients with pulmonary TB with preserved sensitivity of the pathogen to drugs. Results. After 3 months of treatment in group I remained 11.9 % bacterial excretion. After 3 months of treatment in group II there was a decrease in the activity of macrophages against the background of the termination of bacterial excretion and a decrease in the levels of MMP‑9, OSS and AS, which indicates a slowdown of the destruction processes against the background of low fibrotic activity. After 3 months of treatment in group I, fibrosis was active, accompanied by an increase in OSS levels and a decrease in OS levels. Slow sputum conversion in group I was accompanied by a slow (8.2 %) decrease in the ratio of MMP‑9 / TIMP‑1 due to further increase in the level of MMP‑9. Conclusions. In group I, there was a significantly higher activity of the destruction processes, while in group II, there was a lower activity of the fibrotic processes.
- 19 November 2019
- Published by Communicable Diseases Intensive Care Association in Infusion & Chemotherapy
- No. 3
Open AccessStudy of Mechanisms of Pulmonal Tissue Treatment in Destructive Tuberculosis
Introduction. Disruption of the extracellular matrix is one of the most important pathological events in the formation of residual changes in lung tissue in tuberculous inflammation. Аim. Investigation of the dynamics of connective tissue reorganization in lung tuberculosis with a different profile of pathogen resistance to antituberculosis drugs. Materials and methods. 124 patients with new cases of pulmonary TB: group I (n=84) – patients with multidrugresistant TB; group II (n=40) – patients with pulmonary TB with preserved sensitivity of the pathogen to drugs. Results. After 3 months of treatment in group I remained 11.9 % bacterial excretion. After 3 months of treatment in group II there was a decrease in the activity of macrophages against the background of the termination of bacterial excretion and a decrease in the levels of MMP‑9, OSS and AS, which indicates a slowdown of the destruction processes against the background of low fibrotic activity. After 3 months of treatment in group I, fibrosis was active, accompanied by an increase in OSS levels and a decrease in OS levels. Slow sputum conversion in group I was accompanied by a slow (8.2 %) decrease in the ratio of MMP‑9 / TIMP‑1 due to further increase in the level of MMP‑9. Conclusions. In group I, there was a significantly higher activity of the destruction processes, while in group II, there was a lower activity of the fibrotic processes.
- Open Access
- 24 September 2019
- Published by Communicable Diseases Intensive Care Association in Infusion & Chemotherapy
- No. 2
Pathophysiological Mechanisms Destruction of the Lung Connective Tissue in Tuberculosis
Background. The restructuring of the lung tissue stroma during destructive tuberculosis is one of the most important pathological events in the formation of residual changes in the lung tissue during tuberculosis inflammation. Most patients with tuberculosis have destructive forms of this disease. Therefore, studies of pathomorphological changes in the pulmonary tissue of tuberculosispatients are very relevant. It is known that the formation of decavities in volves the destruction of the extracellular matrix, which includes collagen fibers that support the structure of the lungs. The destruction of this matrix leads to the destruction of lung tissue and is a consequence of the activity of proteinase enzymes. One of the products of the destruction of collagen fibers of the lung tissue is oxyproline and its fractions. It has been proventhatin the lungs collagen fibers break down matrix metalloproteinases (MMPs), which belong to the family of proteinases, and are able to affectall component soft he extracellular matrix. The process of MMP synthesis is regulated at the transcription level, and the irproteolytic activity is controlled by proenzymes, as well as inhibition of active enzymes by endogenous inhibitors, α2-macroglobulin and tissue inhibitors of metalloproteinases (TIMP), which play an important role in fibrosis processes. However, it is important not only the level of MMP, but also their ratio with TIMP. An increase in the level of TIMP over MMP leads to the degradation of capillaries of the interalveolar septa, while the predominance of MMP over TIMP leads to the destruction of the component soft he extracellular matrix. Recent studies indicate the role of aldosterone in the processes of fibrosis. It is able to activate blood monocytes, induce in flammation, lead to impaired fibrinolysis. Also aldosterone is able to enhance the synthesis and accumulation of collagen. Elevated levels of aldosterone, stimulating the growth of smooth muscle fibers, contribute to the development of fibrosis in the lungs. There is evidence that aldosterone is able to enhance the degradation of the extracellular matrix through the activation of MMP. Conclusions. Thus, the destruction of the extracellular matrixis one of the most important pathological event sin the formation of residual changes in the lung tissue with tuberculous inflammation.
- 24 September 2019
- Published by Communicable Diseases Intensive Care Association in Infusion & Chemotherapy
- No. 2
Open AccessPathophysiological Mechanisms Destruction of the Lung Connective Tissue in Tuberculosis
Background. The restructuring of the lung tissue stroma during destructive tuberculosis is one of the most important pathological events in the formation of residual changes in the lung tissue during tuberculosis inflammation. Most patients with tuberculosis have destructive forms of this disease. Therefore, studies of pathomorphological changes in the pulmonary tissue of tuberculosispatients are very relevant. It is known that the formation of decavities in volves the destruction of the extracellular matrix, which includes collagen fibers that support the structure of the lungs. The destruction of this matrix leads to the destruction of lung tissue and is a consequence of the activity of proteinase enzymes. One of the products of the destruction of collagen fibers of the lung tissue is oxyproline and its fractions. It has been proventhatin the lungs collagen fibers break down matrix metalloproteinases (MMPs), which belong to the family of proteinases, and are able to affectall component soft he extracellular matrix. The process of MMP synthesis is regulated at the transcription level, and the irproteolytic activity is controlled by proenzymes, as well as inhibition of active enzymes by endogenous inhibitors, α2-macroglobulin and tissue inhibitors of metalloproteinases (TIMP), which play an important role in fibrosis processes. However, it is important not only the level of MMP, but also their ratio with TIMP. An increase in the level of TIMP over MMP leads to the degradation of capillaries of the interalveolar septa, while the predominance of MMP over TIMP leads to the destruction of the component soft he extracellular matrix. Recent studies indicate the role of aldosterone in the processes of fibrosis. It is able to activate blood monocytes, induce in flammation, lead to impaired fibrinolysis. Also aldosterone is able to enhance the synthesis and accumulation of collagen. Elevated levels of aldosterone, stimulating the growth of smooth muscle fibers, contribute to the development of fibrosis in the lungs. There is evidence that aldosterone is able to enhance the degradation of the extracellular matrix through the activation of MMP. Conclusions. Thus, the destruction of the extracellular matrixis one of the most important pathological event sin the formation of residual changes in the lung tissue with tuberculous inflammation.